Fonte: Cancer Chemotherapy and Pharmacology. Unidades: FM, FCF
Assuntos: EMULSÕES (FORMAS FARMACÊUTICAS), LIPOPROTEÍNAS LDL, NEOPLASIAS (QUIMIOTERAPIA)
ABNT
DIAS, Maria Luiza Nogueira et al. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers. Cancer Chemotherapy and Pharmacology, v. 59, n. 1, p. 105-111, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00280-006-0252-3. Acesso em: 13 out. 2024.APA
Dias, M. L. N., Carvalho, J. P., Rodrigues, D. G., Graziani, S. R., & Maranhão, R. C. (2007). Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers. Cancer Chemotherapy and Pharmacology, 59( 1), 105-111. doi:10.1007/s00280-006-0252-3NLM
Dias MLN, Carvalho JP, Rodrigues DG, Graziani SR, Maranhão RC. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers [Internet]. Cancer Chemotherapy and Pharmacology. 2007 ; 59( 1): 105-111.[citado 2024 out. 13 ] Available from: https://doi.org/10.1007/s00280-006-0252-3Vancouver
Dias MLN, Carvalho JP, Rodrigues DG, Graziani SR, Maranhão RC. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers [Internet]. Cancer Chemotherapy and Pharmacology. 2007 ; 59( 1): 105-111.[citado 2024 out. 13 ] Available from: https://doi.org/10.1007/s00280-006-0252-3